This website uses cookies to enhance the user experience.
||
B

BIOGEN NORWAY AS980 785 122

Purchase and sale
Limited company
Vitaminveien 1A 0485 OSLO, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

BIOGEN NORWAY AS

Operating
Produksjon, distribusjon, markedsføring og salg av helseprodukter, herunder deltagelse i andre selskaper med samme eller lignende formål, samt hva som står i forbindelse med dette.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Links

Organization

CEO
EM

Erik Magnus Bodin1981

Chairman of the board
SF

Sergio Ferreira Da Silva Teixeira1973

Years since formation
27 years
since Jun 17, 1999
Type
Limited company
VAT registered
Yes
Number of employees
7

Ownership

Number of shares and share classes
100
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2025
292,180,080
NOK
Annual total result 2025
11,840,175
NOK
Last update: Jul 27, 2026

Management

Management / administration

NameRoleShares
EM

Erik Magnus Bodin

1981

Managing Director/CEO-

Board

NameRoleShares
SF

Sergio Ferreira Da Silva Teixeira

1973

Chairman-
MK

Mehtap Kulbay

1978

Board Member-
EM

Erik Magnus Bodin

1981

Board Member-

Others

NameRoleShares
H
HKW NORGE MOMENTUM AS
Auditor-
A
AZETS INSIGHT AS
Accountant-
Last update: Aug 1, 2026

Ownership

Company shareholders

NameShare classTotal number of sharesShare
II

Idec International Bvi Biogen

Ordinary shares
100
100 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
292,180,080
287,945,651
253,925,221
284,384,737
385,429,393
Annual Total Result
11,840,175
12,064,534
9,493,013
7,449,749
13,704,668
Total assets
0
233,915,002
210,747,664
198,401,506
216,560,030
Total liabilities
0
48,695,674
37,592,871
34,739,726
60,347,999
Total equity
0
185,219,328
173,154,793
163,661,780
156,212,030

P&L

Year20252024202320222021
Total operating income
292,180,080
287,945,651
253,925,221
284,384,737
385,429,393
Total operating costs
282,388,774
277,870,726
244,187,977
274,590,044
367,456,085
Operating result
9,791,305
10,074,925
9,737,245
9,794,693
17,973,308
Financial income/costs
5,416,323
5,400,653
2,455,165
-230,698
-390,415
Profit before tax
15,207,628
15,475,578
12,192,410
9,563,994
17,582,893
Total tax & extraordinary income/cost
3,367,453
3,411,044
2,699,397
2,114,245
3,878,225
Annual Total Result
11,840,175
12,064,534
9,493,013
7,449,749
13,704,668

Balance overview

Year20252024202320222021
Total fixed assets
0
217,307
180,651
259,866
339,968
Total current assets
0
233,697,695
210,567,013
198,141,640
216,220,062
Total assets
0
233,915,002
210,747,664
198,401,506
216,560,030
Short term debt
0
48,695,674
37,592,871
34,739,726
60,347,999
Long term debt
0
0
0
0
0
Total liabilities
0
48,695,674
37,592,871
34,739,726
60,347,999
Contributed capital
0
100,000
100,000
100,000
100,000
Retained earnings
0
185,119,328
173,054,793
163,561,780
156,112,030
Total equity
0
185,219,328
173,154,793
163,661,780
156,212,030
Total equity and liabilities
0
233,915,002
210,747,664
198,401,506
216,560,029

Classification

21st company classification
BETA
Industrial large enterprise
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods